During the past decade, The Neurology group conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Neurology group" #1 sponsor was "Pfizer" with 2 trials, followed by "ACADIA Pharmaceuticals Inc." with 1 trials sponsored, "Actelion" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "The Neurology group" are "Acute Treatment of Migraine" (1 trials), "Migraine" (1 trials), "Multiple Sclerosis" (1 trials), "Neurobehavioral Disinhibition" (1 trials) and "Pediatric Migraine" (1 trials). Many other conditions were trialed in "The Neurology group" in a lesser frequency.

Most popular intervention types in "The Neurology group" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "AVP-786" (1 trials), "Erenumab" (1 trials), "Matching placebo" (1 trials), "Pimavanserin" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Neurology group" are 6 trials for "All" genders.

Currently, there are NaN active trials in "The Neurology group". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in The Neurology group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Neurology group, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".